- Report
- November 2025
- 189 Pages
Global
From €3146EUR$3,500USD£2,731GBP
- Report
- November 2025
- 596 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- October 2025
- 573 Pages
Global
From €6427EUR$7,150USD£5,579GBP
- Report
- July 2025
- 765 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- April 2025
- 469 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- December 2025
- 481 Pages
Global
From €4314EUR$4,799USD£3,744GBP
- Report
- October 2025
- 274 Pages
Global
From €4180EUR$4,650USD£3,628GBP
- Report
- August 2025
- 160 Pages
Global
From €2996EUR$3,333USD£2,601GBP
- Report
- April 2025
- 388 Pages
Global
From €4180EUR$4,650USD£3,628GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- October 2025
- 100 Pages
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- January 2026
- 280 Pages
Global
From €3247EUR$3,613USD£2,819GBP
€3820EUR$4,250USD£3,316GBP
- Report
- October 2025
- 141 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- September 2025
- 144 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- June 2025
- 141 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- May 2025
- 143 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- June 2025
- 200 Pages
Global
From €2238EUR$2,490USD£1,943GBP
- Report
- April 2025
- 200 Pages
Global
From €2238EUR$2,490USD£1,943GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 196 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more